A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
D031841:Aconitum / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D003331:Coronary Vessels / Q000502:physiology; D004285:Dogs; D004562:Electrocardiography; D004837:Epinephrine / Q000494:pharmacology; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D010042:Ouabain / Q000494:pharmacology; D011802:Quinidine / Q000627:therapeutic use*; D013610:Tachycardia / Q000139:chemically induced; D014700:Verapamil / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D004983:Ethanolamines; D010042:Ouabain; D014700:Verapamil; D011802:Quinidine; D004837:Epinephrine